Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival

Stem Cell Research

Volumn 12, Issue 2, 2014, Pages 584-598

  Bourgine, Paul ^a   Le Magnen, Clementine ^a   Pigeot, Sebastien ^a   Geurts, Jeroen ^a   Scherberich, Arnaud ^a   Martin, Ivan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD146 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; LUCIFERASE; THY 1 ANTIGEN; UVOMORULIN; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE SIALOPROTEIN; CASPASE 9; DNA; OSTEOCALCIN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR RUNX2;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CARCINOGENICITY; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL FUNCTION; CELL IMMORTALIZATION; CELL LINE; CELL SURVIVAL; CELL TRACKING; CLONE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; OSSIFICATION; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; BONE MARROW CELL; CELL CULTURE; CELL GROWTH; CYTOLOGY; FEMALE; METABOLISM; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; SCID MOUSE; ADIPOGENESIS; ADULT; ANIMAL TISSUE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL CLONE; CELL CYCLE REGULATION; CELL ENGINEERING; CELL SELECTION; CHONDROGENESIS; DNA FINGERPRINTING; GENETIC TRANSDUCTION; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPING; LUCIFERASE ASSAY; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BONE MARROW CELLS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELLS, CULTURED; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED;

EID: 84894275930     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.12.006     Document Type: Article

References (46)

1. Abdallah B.M., Haack-Sorensen M., Burns J.S., Elsnab B., Jakob F., Hokland P., Kassem M. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem. Biophys. Res. Commun. 2005, 326:527-538.
2. Barbero A., Ploegert S., Heberer M., Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 2003, 48:1315-1325.
3. Ben-David U., Mayshar Y., Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011, 9:97-102.
4. Benayahu D., Akavia U.D., Shur I. Differentiation of bone marrow stroma-derived mesenchymal cells. Curr. Med. Chem. 2007, 14:173-179.
5. Bermudez Y., Erasso D., Johnson N.C., Alfonso M.Y., Lowell N.E., Kruk P.A. Telomerase confers resistance to caspase-mediated apoptosis. Clin. Interv. Aging 2006, 1:155-167.
6. Boker W., Yin Z., Drosse I., Haasters F., Rossmann O., Wierer M., Popov C., Locher M., Mutschler W., Docheva D., Schieker M. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J. Cell. Mol. Med. 2008, 12:1347-1359.
7. Braccini A., Wendt D., Jaquiery C., Jakob M., Heberer M., Kenins L., Wodnar-Filipowicz A., Quarto R., Martin I. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 2005, 23:1066-1072.
8. Burns J.S., Abdallah B.M., Guldberg P., Rygaard J., Schroder H.D., Kassem M. Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 2005, 65:3126-3135.
9. Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M., Sedivy J.M., Weinberg R.A. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14723-14728.
10. Daga A., Muraglia A., Quarto R., Cancedda R., Corte G. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther. 2002, 9:915-921.
11. Dai L.J., Moniri M.R., Zeng Z.R., Zhou J.X., Rayat J., Warnock G.L. Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett. 2011, 305:8-20.
12. Deeb D., Gao X., Liu Y., Kim S.H., Pindolia K.R., Arbab A.S., Gautam S.C. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity. Biochem. Biophys. Res. Commun. 2012, 422:561-567.
13. Du Y., Jenkins N.A., Copeland N.G. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 2005, 106:3932-3939.
14. Frank O., Heim M., Jakob M., Barbero A., Schafer D., Bendik I., Dick W., Heberer M., Martin I. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 2002, 85:737-746.
15. Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C.M., Quigley M.F., Almeida J.R., Gostick E., Yu Z., Carpenito C., Wang E., Douek D.C., Price D.A., June C.H., Marincola F.M., Roederer M., Restifo N.P. A human memory T cell subset with stem cell-like properties. Nat. Med. 2011, 17:1290-1297.
16. Huang G., Zheng Q., Sun J., Guo C., Yang J., Chen R., Xu Y., Wang G., Shen D., Pan Z., Jin J., Wang J. Stabilization of cellular properties and differentiation mutilpotential of human mesenchymal stem cells transduced with hTERT gene in a long-term culture. J. Cell. Biochem. 2008, 103:1256-1269.
17. Indran I.R., Hande M.P., Pervaiz S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res. 2011, 71:266-276.
18. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64:295-312.
19. Jakob M., Demarteau O., Schafer D., Hintermann B., Dick W., Heberer M., Martin I. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J. Cell. Biochem. 2001, 81:368-377.
20. Jun E.S., Lee T.H., Cho H.H., Suh S.Y., Jung J.S. Expression of telomerase extends longevity and enhances differentiation in human adipose tissue-derived stromal cells. Cell. Physiol. Biochem. 2004, 14:261-268.
21. Kidd S., Spaeth E., Dembinski J.L., Dietrich M., Watson K., Klopp A., Battula V.L., Weil M., Andreeff M., Marini F.C. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 2009, 27:2614-2623.
22. Lai W.T., Krishnappa V., Phinney D.G. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels. Stem Cells 2011, 29:1102-1111.
23. Latil A., Vidaud D., Valeri A., Fournier G., Vidaud M., Lidereau R., Cussenot O., Biache I. htert expression correlates with MYC over-expression in human prostate cancer. Int. J. Cancer 2000, 89:172-176.
24. Liang W., Ye D., Dai L., Shen Y., Xu J. Overexpression of hTERT extends replicative capacity of human nucleus pulposus cells, and protects against serum starvation-induced apoptosis and cell cycle arrest. J. Cell. Biochem. 2012, 113:2112-2121.
25. Maniatopoulos C., Sodek J., Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 1988, 254:317-330.
26. Mihara K., Imai C., Coustan-Smith E., Dome J.S., Dominici M., Vanin E., Campana D. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br. J. Haematol. 2003, 120:846-849.
27. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp. Biol. Med. 2001, 226:507-520. (Maywood).
28. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci. 2000, 113(Pt 7):1161-1166.
29. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
30. Nienhuis A.W., Dunbar C.E., Sorrentino B.P. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 2006, 13:1031-1049.
31. Phinney D.G., Kopen G., Righter W., Webster S., Tremain N., Prockop D.J. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J. Cell. Biochem. 1999, 75:424-436.
32. Piper S.L., Wang M., Yamamoto A., Malek F., Luu A., Kuo A.C., Kim H.T. Inducible immortality in hTERT-human mesenchymal stem cells. J. Orthop. Res. 2012, 30:1879-1885.
33. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
34. Ramos C.A., Asgari Z., Liu E., Yvon E., Heslop H.E., Rooney C.M., Brenner M.K., Dotti G. An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells 2010, 28:1107-1115.
35. Sacchetti B., Funari A., Michienzi S., Di C.S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M., Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
36. Sadr N., Pippenger B.E., Scherberich A., Wendt D., Mantero S., Martin I., Papadimitropoulos A. Enhancing the biological performance of synthetic polymeric materials by decoration with engineered, decellularized extracellular matrix. Biomaterials 2012, 33:5085-5093.
37. Serakinci N., Guldberg P., Burns J.S., Abdallah B., Schrodder H., Jensen T., Kassem M. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 2004, 23:5095-5098.
38. Sharpless N.E., Depinho R.A. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest. 2004, 113:160-168.
39. Siddappa R., Licht R., van, B.C., de, B.J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J. Orthop. Res. 2007, 25:1029-1041.
40. Siddiqi S., Mills J., Matushansky I. Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas. Curr. Stem. Cell. Res. Ther. 2010, 5:63-73.
41. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., Jensen T.G., Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 2002, 20:592-596.
42. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., Jensen T.G., Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 2002, 20:592-596.
43. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
44. Straathof K.C., Pule M.A., Yotnda P., Dotti G., Vanin E.F., Brenner M.K., Heslop H.E., Spencer D.M., Rooney C.M. An inducible caspase 9 safety switch for T-cell therapy. Blood 2005, 105:4247-4254.
45. Tarte K., Gaillard J., Lataillade J.J., Fouillard L., Becker M., Mossafa H., Tchirkov A., Rouard H., Henry C., Splingard M., Dulong J., Monnier D., Gourmelon P., Gorin N.C., Sensebe L. Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 2010, 115:1549-1553.
46. Yang B., Wu X., Mao Y., Bao W., Gao L., Zhou P., Xie R., Zhou L., Zhu J. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Neurosurgery 2009, 65:610-624.